Abstract
1 This double-blind study in 60 hospitalized female patients comparing midazolam 15 mg, oxazepam 15 mg and placebo, demonstrated an inter-group difference in favour of midazolam with regard to efficacy.
2 The sleep parameters of onset latency and duration were improved by midazolam.
3 All three compounds were very well tolerated and no withdrawal symptoms were observed.
4 Midazolam, in an oral dose of 15 mg, can thus be regarded as an effective, well-tolerated agent for the treatment of sleep disorders.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amrein R., Cano J. P., Eckert M., Coassolo P. Pharmakokinetik von Midazolam nach intravenöser Verabreichung. Arzneimittelforschung. 1981;31(12A):2202–2205. [PubMed] [Google Scholar]
- Grote B., Doenicke A., Kugler J., Suttmann H., Loos A. Intramuskuläre Applikation von Midazolam. Wirkung auf ZNS und Atmung. Arzneimittelforschung. 1981;31(12A):2224–2225. [PubMed] [Google Scholar]
- Lupolover R., Buch J. P. Evaluation of efficacy and safety of midazolam administered orally in sleep disorders. A dose-finding study. Arzneimittelforschung. 1981;31(12A):2281–2283. [PubMed] [Google Scholar]